Who is in charge of assessing therapeutic drug monitoring? The case of imatinib.

Details

Serval ID
serval:BIB_15E65DE45ADE
Type
Article: article from journal or magazin.
Publication sub-type
Letter (letter): Communication to the publisher.
Collection
Publications
Institution
Title
Who is in charge of assessing therapeutic drug monitoring? The case of imatinib.
Journal
Lancet Oncology
Author(s)
Buclin T., Widmer N., Biollaz J., Decosterd L.A.
ISSN
1474-5488 (Electronic)
ISSN-L
1470-2045
Publication state
Published
Issued date
2011
Peer-reviewed
Oui
Volume
12
Number
1
Pages
9-11
Language
english
Notes
Publication types: Journal Article
Keywords
Antineoplastic Agents/blood, Drug Industry, Drug Monitoring, Humans, Neoplasms/drug therapy, Neoplasms/metabolism, Piperazines/blood, Protein Kinase Inhibitors/blood, Pyrimidines/blood
Pubmed
Web of science
Create date
26/01/2011 14:11
Last modification date
20/08/2019 13:45
Usage data